The Effect of Memantine on Cognitive Impairments in Patients with Brain Tumour under Radiotherapy: A Randomized Clinical Trial Study
محل انتشار: مجله سرطان خاورمیانه، دوره: 14، شماره: 2
سال انتشار: 1402
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 59
فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_MISJ-14-2_008
تاریخ نمایه سازی: 25 آبان 1402
چکیده مقاله:
Background: Cognitive impairment is one of the common problems in patients undergoing radiotherapy, but there is no way to prevent it until this time. The aim of this study was to determine the effect of memantine on the prevention of cognitive impairment in patients with brain tumour undergoing radiotherapy.Method: In this clinical trial study, ۷۰ patients under radiotherapy were selected and randomly divided into two groups. The first group received ۱۰ mg of memantine tablets daily for six months and the second group received placebo at the same dose and time. Cognitive impairment was evaluated through Mini-Mental Status Examination questionnaire and compared between the two groups.Results: The mean score of cognitive impairment before and after radiotherapy in the control and intervention groups were ۲۷.۹۷ ± ۱.۵۲ and ۲۷.۶۶ ± ۱.۳۵ (P = ۰.۲۶), in the following month were ۲۷.۷۴ ± ۱.۷۴ and ۲۷.۶۳ ± ۱.۳۵ (P = ۰.۷۳), in the following three months were ۲۳.۱۷ ± ۱.۸۱ and ۲۴.۷۷ ± ۱.۴۴ (P < ۰.۰۰۱), and in the following six months were ۲۰.۶۶ ± ۱.۸ and ۲۳.۱۷ ± ۱.۴۲ (P < ۰.۰۰۱). In addition, changes in cognitive impairment score were significantly different between the two groups (P < ۰.۰۰۱).Conclusion: It seems that memantine is effective in preventing the cognitive impairment in patients undergoing radiotherapy following brain tumour surgery and the implementation of this referee can be associated with improved cognitive function over time.
کلیدواژه ها:
نویسندگان
Simin Hemati
Department of Radio-Oncology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
Hamid Emami
Department of Radio-Oncology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
Susan Andalibi
Department of Radio-Oncology, Medical School, Isfahan University of Medical Sciences, Isfahan, Iran
Ehsan Mohammad Hosseini
Department of Neurosurgery, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran
Shahin Salarvand
Hepatitis Research Center, Nursing and Midwifery Faculty, Lorestan University of Medical Sciences, Khorramabad, Iran
مراجع و منابع این مقاله:
لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :